If you're one of four million people hoping to give up smoking for New Year, you may already know about the anti-smoking drug Zyban. The popular drug is thought to double your chances of quitting ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Mike Stone, of the Patients' Association, said: 'For the peace of mind of the people taking the drug, there should be some kind of inquiry.' Zyban, introduced last June, is a key part of a ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

USA: A recent economic evaluation has highlighted the significant long-term health benefits of tirzepatide and semaglutide in ...

Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...

It doesn't matter how full you are, you can always fit in a bite or two or three of pie and ice cream. Scientists say it has ...

Wellbutrin is the brand name for the antidepressant drug bupropion. The Food and Drug Administration (FDA) approved Wellbutrin in the United States for treating depression in 1985. They approved ...